Study testing a new way to help men prevent HIV
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 29 years old.
- You have had anal sex with a man in the last 6 months.
- You are not currently taking PrEP and are open to learning more about starting.
- You are HIV negative.
- You own a smartphone that can download apps and send texts.
- You read and write comfortably.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ways to improve how well people take PrEP (a medicine that helps prevent HIV) consistently. It may help you if you’re at higher risk and are not currently on PrEP, especially around starting and staying on it.
This study tests a '2-1-1' on-demand PrEP strategy for cisgender men who have sex with men. It aims to see if taking PrEP only around the time of sex is safe and effective. If you are interested in starting or currently taking PrEP this way, you may be eligible.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests a mobile app to help young men who have sex with men stay HIV-negative. It focuses on people who have had condomless anal sex recently and are not using PrEP.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
Hear when a new Sexually Transmitted Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.